No one cares about rare disease in this company. It’s a distraction and a cost. It looks good on paper but that’s about it. Novo has bigger issues to solve.
Watch it fall back down. Hope you sold.
SP is horrible. Can't be trusted.
SP is the only reason I left Phathom. He can't be trusted. Snake in the grass.